Method of treating ischemic disease by intramuscular administration of Hepatocyte growth factor
US6887477B1 · kind B1 · utility
8Cited by
5References
3Claims
0Family size
Inventors
Key dates
| Filing date | Aug 4, 1999 |
| Grant date | May 3, 2005 |
| Priority date | — |
| Expiry date | Aug 4, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Preparations to be administered for treating or preventing ischemic diseases or arterial diseases which contain Hepatocyte growth factor (HGF) as an active ingredient. The preparations provide such effect that HGF concentration in an affected region to which HGF was administered is maintained, a half-life is longer, a dose can be reduced, and other organs except the affected region are less affected in comparison with intravenous administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.